![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
3MB |
![[thumbnail of Supplemental Information]](https://edoc.mdc-berlin.de/style/images/fileicons/other.png) |
Other (Supplemental Information)
3MB |
| Item Type: | Article |
|---|---|
| Title: | Diagnosing recipient- vs. donor-derived posttransplant myelodysplastic neoplasm via targeted single-cell mutational profiling |
| Creators: |
Ihlow, J., Penter, L.  ORCID: https://orcid.org/0000-0002-9060-0207, Vuong, L.G., Bischoff, P., Obermayer, B. ORCID: https://orcid.org/0000-0002-9116-630X, Trinks, A. ORCID: https://orcid.org/0000-0001-9983-1506, Blau, O., Behnke, A., Conrad, T. ORCID: https://orcid.org/0000-0001-5618-6295, Morkel, M. ORCID: https://orcid.org/0000-0002-2553-9999, Wu, C.J., Westermann, J., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, von Brünneck, A.C., Blüthgen, N. ORCID: https://orcid.org/0000-0002-0171-7447, Horst, D. and Praktiknjo, S.D. ORCID: https://orcid.org/0000-0002-0186-5271
|
| Abstract: | BACKGROUND: Distinguishing donor- vs. recipient-derived myelodysplastic neoplasm (MDS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is challenging and has direct therapeutical implications. METHODS: Here, we took a translational approach that we used in addition to conventional diagnostic techniques to resolve the origin of MDS in a 38-year-old patient with acquired aplastic anemia and evolving MDS after first allo-HSCT. Specifically, we used single-cell transcriptional profiling to differentiate between donor- and recipient-derived bone marrow cells and established a strategy that additionally allows identification of cells carrying the MDS-associated U2AF1(S34Y) variant. RESULTS: The patient exhibited mixed donor chimerism combined with severely reduced erythropoiesis and dysplastic morphology within the granulocytic and megakaryocytic lineage along with the MDS-associated U2AF1(S34Y) mutation in the bone marrow. Single-cell transcriptional profiling together with targeted enrichment of the U2AF1(S34Y)-specific locus further revealed that, while the immune compartment was mainly populated by donor-derived cells, myelopoiesis was predominantly driven by the recipient. Additionally, concordant with recipient-derived MDS, we found that U2AF1(S34Y)-mutated cells were exclusively recipient derived with X but not Y chromosome-specific gene expression. CONCLUSION: Our study highlights the clinical potential of integrating high-resolution single-cell techniques to resolve complex cases for personalized treatment decisions. |
| Keywords: | MDS, Allo-HSCT, Mixed Chimerism, Aplastic Anemia, Precision Diagnostics, Single-Cell, Targeted Sequencing, Mutational Profiling, U2AF1S34Y, Personalized Medicine |
| Source: | Med |
| ISSN: | 2666-6340 |
| Publisher: | Cell Press |
| Volume: | 6 |
| Number: | 4 |
| Page Range: | 100548 |
| Date: | 11 April 2024 |
| Official Publication: | https://doi.org/10.1016/j.medj.2024.11.001 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
